Rare diseases
Investigational molecules
Locations
Back to France649 clinical trials in Pierre Benite, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma
FranceStudy of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery
FranceFranceStudy on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines
FranceStudy of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease
FranceStudy Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments
FranceFranceStudy on the Safety and Effectiveness of Pembrolizumab and Drug Combination for Patients with Stage III Melanoma Eligible for Neoadjuvant Therapy
FranceStudy of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer
FranceStudy on the Safety and Effectiveness of Pembrolizumab and Tretinoin in Patients with PD-1 Refractory Melanoma
FranceStudy on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin
FranceStudy on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on vaccine development against major viral infections. Studies include evaluations of new treatments for influenza, cytomegalovirus, and yellow fever.
Research aims to enhance prevention and protection against these significant viral threats.
Groundbreaking research in inflammatory bowel diseases, exploring innovative therapeutic approaches including fecal microbiota transplantation for both Crohn's disease and ulcerative colitis.
Studies focus on developing alternative treatment strategies for patients with limited therapeutic options.
Comprehensive research into blood cancers and solid tumors, including multiple myeloma, leukemia, and advanced prostate cancer. Trials evaluate novel therapeutic combinations and targeted treatments.
Focus on developing more effective and personalized treatment approaches.
Studies addressing heart failure prevention, chronic kidney disease, and metabolic disorders. Research includes evaluation of novel drug combinations and therapeutic strategies.
Emphasis on preventing disease progression and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
